Company intelligence / Profile preview
Aptevo Therapeutics
Seattle, Washington, United Statesaptevotherapeutics.com ↗
- Ownership
- Public · APVO
- Employees
- ~37
- Development stage
- Phase 1
01
Overview
Aptevo’s lead candidate Mipletamig has shown promising results in AML with high remission rates reported in the RAINIER trial. ALG.APV‑527 has demonstrated stable disease in a significant proportion of patients with solid tumors during dose escalation studies. Three additional candidates are at the preclinical stage targeting various tumor types.
- Therapeutic areas
- Oncology
- Modalities
- Bispecific antibodies (bispecific immunotherapies)Multi-specific immunotherapeutic proteins
- Industry
- Biotech
02
Drug pipeline
10 assets9 more assets in the full pipeline.
03
Partnerships
Alligator Bioscience AB – co-development of ALG.APV–527 for solid tumorsCMC ICOS Biologics – manufacturing partnership for supply of clinical materialsEmergent BioSolutions Inc. – historical agreements including trademark licensing and manufacturing services after spin-out from Emergent BioSolutions Inc.Midcap Financial Trust – financial agreement partnerPiper Jaffray & Co., Lincoln Park Capital Fund – financial partners/investorsSaol International Limited/Venus Bio Therapeutics Sub LLC – transaction partners on asset sales/acquisitions
04
Financials
- Market cap
- $2.8M
- Total revenue
- $0
- Enterprise value
- $-2.8M
Beyond the preview
Go deeper on Aptevo Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aptevo Therapeutics.